The introduction of cell and gene therapies has brought about tremendous changes in the contemporary practice of medicine, providing an array of targeted therapies to treat diseases that used to be very challenging or unmanageable to treat. However, as the development of such therapies moves on from experimental to manufacturing stages, companies have to pay special attention to quality, safety, and regulatory compliance at all production stages.
While the need for sterility and potency tests is quite obvious, there is another aspect of the process that does not get as much attention as it deserves, and it is the issue of endotoxin testing. The fact is that even low levels of endotoxins may affect the safety of the product, impact patient outcomes, and slow down the production process.
In the case of companies providing cell therapy manufacturing services, the problem of endotoxin testing services should not be perceived only as a stage of the process of product release.
Understanding Endotoxins and Their Impact
Endotoxins are lipopolysaccharides present in the outer cell wall of Gram-negative bacteria. Endotoxins can be present in the manufacturing environment, raw materials, water systems, and manufacturing equipment due to bacterial death and multiplication.
In contrast to living microorganisms, endotoxins have a high heat resistance and might not be destroyed by standard sterilization processes. In the case of absence of microbial contamination, endotoxins might still remain and cause serious hazards.
The introduction of endotoxins for patients under cell or gene therapies might lead to such complications as:
- Fever
- Intense inflammatory reactions
- Hypotension
- Damage to organs in severe cases
- Lower efficiency of therapy
Thus, the regulation of endotoxins in case of advanced therapies might be even more important.
The Reasons Why Cell and Gene Therapy Manufacturing Is Challenging
In most cases, traditional drug manufacturing processes allow for additional purification or sterilization of the product prior to its release to market.
For cell and gene therapy products, there is no such option, as the treatment process is highly delicate.
In other words, any harsh processing, excessive heat, chemicals, or purification can destroy the therapeutic substance.
That is why it is essential to ensure that endotoxins do not contaminate the product.
Some possible ways for endotoxin contamination include:
- Starting raw material
- Media used for cell culture
- Single-use items
- Water system
- Laboratory instruments
- Human factor
- Environmental contamination
Moving Beyond Final Product Testing
Endotoxin testing for batch release is one of the common practices employed by many companies. Batch release testing is important, but basing your end-product tests alone is risky.
If endotoxin testing is done late in the manufacturing process, there will be adverse effects such as:
- Batch rejection
- Delays in the manufacturing process
- Increase in the manufacturing cost
- Messes up the schedule of patients’ treatment
- Observations from the regulatory authorities
- The better way of doing things would be in-process testing.
In-process testing enables early identification of the problem and helps the manufacturer to take action before the entire batch gets contaminated.
The Role of In-Process Testing
Quality control in modern manufacturing tends to focus more on proactive testing than on reactive measures.
Process testing fits within this trend by allowing quality to be controlled in the manufacturing process rather than once production is complete.
Examples of possible control points include:
- Raw materials prior to processing
- Cell culture
- Process purification
- Buffer preparation
- Formulation for filling
This multi-tiered system has several benefits.
Quick Problem Detection
If contamination is detected at an early stage, manufacturers can pinpoint the source of the problem within the process rather than evaluating the entire production process.
Reduced Manufacturing Costs
Many advanced therapies use costly raw materials and take time to manufacture. Identifying the problem earlier will save costs.
Improved Process Knowledge
Consistent monitoring allows manufacturers to understand contamination patterns and optimize their processes.
Regulatory Compliance
Regulatory authorities tend to place increased importance on process control.
Help with Regulatory Compliance
Regulatory bodies worldwide are increasingly stringent in their requirements regarding quality risk management and contamination control.
It is expected that the manufacturer will provide evidence of:
- Validation of testing methodologies
- Control of manufacturing environment
- Strategic monitoring based on risk analysis
- Complete documentation
- Consistent performance of processes
Endotoxin control assists with cGMP compliance and overall quality management systems.
Companies that incorporate endotoxin monitoring into their manufacturing process usually develop good inspection readiness while reducing compliance risks.
Implementation of Endotoxin Control in Manufacturing
Endotoxin control starts well before the manufacturing process commences.
Usually, successful manufacturers have multiple preventive barriers that can ensure contamination control.
They include:
Raw Material Qualification
Quality suppliers shall be selected and tested; their documentation shall be appropriate for incoming materials.
Water System Control
Water is still one of the key sources of potential endotoxin contamination. Regular monitoring and servicing help to minimize risks.
Equipment Validation
Equipment used for manufacturing shall be properly cleaned, serviced, and validated to avoid contamination between manufacturing runs.
Environmental Monitoring
Regular environmental monitoring helps identify any contamination risks prior to the manufacturing process.
Training
Employees shall be trained for recognizing contamination risks and aseptic techniques.
Why Experienced Testing Partners Matter
Cell and gene therapy production is characterized by complex analytical challenges that go beyond what pharmaceuticals require.
Testing services from experienced laboratories can account for the specific features of advanced therapy products and develop testing strategies that align with manufacturing processes.
Experienced analytical partners may provide assistance in such areas as:
- Method development
- Method validation
- Support of compliance with regulatory requirements
- Batch release testing
- Risk assessment
- Continuous quality monitoring
Collaboration with experienced testing partners enables manufacturers to focus on process development without worrying about the quality of the analysis.
Quality Is an Ongoing Challenge
As cell and gene therapies continue to evolve, manufacturing challenges are expected to become even more stringent.
Regulators, health care professionals, and patients have high expectations when it comes to the safety and consistency of therapies.
Instead of seeing endotoxin testing as one particular point before release of the product to market, it should become a part of the quality by design approach, which should be applied at every stage of manufacturing.
Preventive contamination control in combination with in-process testing creates a robust quality approach and reduces risks.
Final Thoughts
One of the most promising fields in today’s medicine is cell and gene therapy, which requires highly developed approaches to quality control. Although the presence of endotoxins may remain undetected, their impacts on the producer and the patient can be serious.
The inclusion of full endotoxin testing services into the manufacturing process, rather than at the drug release stage, enables timely risk detection, cost reduction through lower failure rates, and improved regulatory compliance. Coupled with effective cell therapy manufacturing services and timely testing, such an approach provides greater efficiency and safety for producers and patients.
As the field of advanced therapies develops, companies that incorporate endotoxin control into their overall quality strategy stand out as leaders.
Partner with Xellera Therapeutics to strengthen your cell and gene therapy manufacturing with reliable endotoxin testing, advanced analytics, and quality-driven solutions.
